Accelerate Diagnostics Inc. Watch

from 8-K 159 pages Accelerate Diagnostics, Inc. as Issuer, the Guarantors Named Herein and U.S. Bank Trust Company, National Association as Trustee and as Notes Collateral Agent Indenture Dated as of August 8, 2024 $15,000,000 Super-Priority Senior Secured Pik Notes Due 2025

from 10-K 3 pages Description of Our Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 16 pages Warrant Agency Agreement Broadridge Corporate Issuer Solutions, LLC and Accelerate Diagnostics, Inc

from S-1/A 23 pages Warrant Agency Agreement Broadridge Corporate Issuer Solutions, LLC and Accelerate Diagnostics, Inc

from S-1/A 13 pages Pre-Funded Warrant to Purchase Stock

from S-1/A 13 pages Warrant to Purchase Stock

from S-1/A 14 pages Form of Warrant Agency Agreement Broadridge Corporate Issuer Solutions, Inc. and Accelerate Diagnostics, Inc

from S-1/A 13 pages Pre-Funded Warrant to Purchase Stock

from S-1/A 13 pages Warrant to Purchase Stock

from 8-K 139 pages Accelerate Diagnostics, Inc. and U.S. Bank Trust Company, National Association, as Trustee and Collateral Agent Indenture Dated as of June 9, 2023 5.00% Senior Secured Convertible Notes Due 2026

from 10-K 3 pages Description of Our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 3 pages Description of Our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-3 62 pages Accelerate Diagnostics, Inc. Indenture Dated as of , 20__ [ ] as Trustee Subordinated Debt Securities

from S-3 57 pages Accelerate Diagnostics, Inc. Indenture Dated as of , 20__ [ ] as Trustee Senior Debt Securities

from 10-K 2 pages Description of Our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 3 pages Fully Paid and Non-Assessable Shares of Common Stock of $.001 Par Value Each of Accelerate Diagnostics, Inc. ==============--­ Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Duly Endorsed or Assigned. This Certificate and the Shares Represented Hereby Are Subject to the Laws of the State of Delaware, and to the Certificate of Incorporation and Bylaws of the Corporation, as Now or Hereafter Amended. This Certificate Is Not Valid Until Countersigned by the Transfer Agent. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Countersigned: Broadridge Corporate Issuer Solutions, Inc. 1717 Arch St., Ste. 1300, Philadelphia, Pa 19103 Transfer Agent By; Authorized Signature

from 8-K 110 pages Accelerate Diagnostics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of March 27, 2018 2.50% Convertible Senior Notes Due 2023

from S-3ASR 62 pages Accelerate Diagnostics, Inc. to as Trustee Indenture Dated as of , 20__ Subordinated Debt Securities

from S-3ASR 57 pages Accelerate Diagnostics, Inc. to as Trustee Indenture Dated as of , 20__ Senior Debt Securities

from S-3/A 3 pages Accelerate Diagnostics, Inc. Incorporated Under the Laws of the State of Delaware Non-Transferable Subscription Rights Certificate Evidencing Non-Transferable Subscription Rights to Purchase Shares of Common Stock, Par Value $0.001 Per Share, of Accelerate Diagnostics, Inc. Subscription Price: $16.80 Per Full Share the Subscription Rights Will Expire if Not Exercised on or Before 5:00 P.M., New York City Time, on April 28, 2014